December 2, 2010
Food and Drug Administration
Attention: Division of Dockets Management (HFA-305)
5630 Fishers Lane, Rm. 1061
Rockville, MD 20852
SUBMITTED ONLINE
RE: Docket No. FDA–2010–D–0482
Dear Reviewer:
As always, we thank you for the privilege of commenting on draft guidances. Comments are attached.
Attachments:
Association of Clinical Research Professionals - Comment
Title: Association of Clinical Research Professionals - Comment
Association of Clinical Research Professionals - Comment
This is comment on Notice
Draft Guidance for Industry and Investigators: Safety Reporting Requirements for Investigational New Drug Applications andBioavailability/Bioequivalence Studies; Availability
View Comment
Attachments:
Association of Clinical Research Professionals - Comment
Title:
Association of Clinical Research Professionals - Comment
Related Comments
View AllPublic Submission Posted: 11/19/2010 ID: FDA-2010-D-0482-0002
Dec 28,2010 11:59 PM ET
Public Submission Posted: 11/29/2010 ID: FDA-2010-D-0482-0003
Dec 28,2010 11:59 PM ET
Public Submission Posted: 12/17/2010 ID: FDA-2010-D-0482-0004
Dec 28,2010 11:59 PM ET
Public Submission Posted: 12/21/2010 ID: FDA-2010-D-0482-0006
Dec 28,2010 11:59 PM ET
Public Submission Posted: 12/21/2010 ID: FDA-2010-D-0482-0007
Dec 28,2010 11:59 PM ET